- Home
- TRNR vs ENVB Comparison
TRNR vs ENVB Comparison
Compare TRNR & ENVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRNR
- ENVB
- Stock Information
- Founded
- TRNR 2017
- ENVB 1994
- Country
- TRNR United States
- ENVB United States
- Employees
- TRNR N/A
- ENVB N/A
- Industry
- TRNR Consumer Electronics/Appliances
- ENVB Biotechnology: Pharmaceutical Preparations
- Sector
- TRNR Technology
- ENVB Health Care
- Exchange
- TRNR Nasdaq
- ENVB Nasdaq
- Market Cap
- TRNR 3.3M
- ENVB 3.3M
- IPO Year
- TRNR 2023
- ENVB N/A
- Fundamental
- Price
- TRNR $2.04
- ENVB $1.72
- Analyst Decision
- TRNR
- ENVB Strong Buy
- Analyst Count
- TRNR 0
- ENVB 1
- Target Price
- TRNR N/A
- ENVB $10.00
- AVG Volume (30 Days)
- TRNR 90.4K
- ENVB 349.7K
- Earning Date
- TRNR 03-31-2025
- ENVB 03-25-2025
- Dividend Yield
- TRNR N/A
- ENVB N/A
- EPS Growth
- TRNR N/A
- ENVB N/A
- EPS
- TRNR N/A
- ENVB N/A
- Revenue
- TRNR $3,180,000.00
- ENVB N/A
- Revenue This Year
- TRNR $1,543.45
- ENVB N/A
- Revenue Next Year
- TRNR $54.84
- ENVB N/A
- P/E Ratio
- TRNR N/A
- ENVB N/A
- Revenue Growth
- TRNR 226.82
- ENVB N/A
- 52 Week Low
- TRNR $1.85
- ENVB $1.62
- 52 Week High
- TRNR $4,760.00
- ENVB $657.00
- Technical
- Relative Strength Index (RSI)
- TRNR 27.86
- ENVB 16.97
- Support Level
- TRNR $2.34
- ENVB $3.88
- Resistance Level
- TRNR $2.55
- ENVB $4.83
- Average True Range (ATR)
- TRNR 0.19
- ENVB 3.87
- MACD
- TRNR 0.02
- ENVB -8.30
- Stochastic Oscillator
- TRNR 19.59
- ENVB 0.22
About TRNR Interactive Strength Inc.
Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue, and personal training revenue.
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. The company's lead program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders.